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Human monocyte-derived dendritic cells (DCs) exposed to pathogen-associated 
molecular patterns (PAMPs) undergo bioenergetic changes that influence the immune 
response. We found that stimulation with PAMPs enhanced glycolysis in DCs, whereas 
oxidative phosphorylation remained unaltered. Glucose starvation and the hexokinase 
inhibitor 2-deoxy-d-glucose (2-DG) modulated cytokine expression in stimulated DCs. 
Strikingly, IL23A was markedly induced upon 2-DG treatment, but not during glucose 
deprivation. Since 2-DG can also rapidly inhibit protein N-glycosylation, we postulated 
that this compound could induce IL-23 in DCs via activation of the endoplasmic retic-
ulum (ER) stress response. Indeed, stimulation of DCs with PAMPs in the presence of 
2-DG robustly activated inositol-requiring protein 1α (IRE1α) signaling and to a lesser 
extent the PERK arm of the unfolded protein response. Additional ER stressors such 
as tunicamycin and thapsigargin also promoted IL-23 expression by PAMP-stimulated 
DCs. Pharmacological, biochemical, and genetic analyses using conditional knockout 
mice revealed that IL-23 induction in ER stressed DCs stimulated with PAMPs was 
IRE1α/X-box binding protein 1-dependent upon zymosan stimulation. Interestingly, we 
further evidenced PERK-mediated and CAAT/enhancer-binding protein β-dependent 
trans-activation of IL23A upon lipopolysaccharide treatment. Our findings uncover that 
the ER stress response can potently modulate cytokine expression in PAMP-stimulated 
human DCs.
Keywords: glycolysis, c/eBPβ, 2-deoxy-d-glucose, fungal patterns, il-23, lactate, unfolded protein response, 
XBP1
Abbreviations: ATF, activating transcription factor; BMDCs, bone marrow-derived dendritic cells; C/EBPβ, CAAT/enhancer-
binding protein β; ChIP, chromatin immunoprecipitation; CHOP, C/EBP homologous protein; COX-2, cyclooxygenase 
2; CREB, cAMP response element-binding protein; DCs, dendritic cells; 2-DG, 2-deoxy-d-glucose; ECAR, extracellular 
acidification rate; eIF2α, elongation initiation factor 2α; ER, endoplasmic reticulum; GFPT1, glutamine-fructose-6-phosphate 
transaminase 1; HIF, hypoxia-inducible factor; IRE1α, inositol-requiring protein 1α; IKK, IκB kinase; MS, mass spectrometry; 
OCR, oxygen consumption rate; PAMPs, pathogen-associated molecular patterns; PERK, protein kinase R-like endoplasmic 
reticulum kinase; PKM, pyruvate kinase M; UPLC, ultraperformance liquid chromatography; UPR, unfolded protein response; 
WT, wild type; XBP1, X-box binding protein 1.
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inTrODUcTiOn
Activation of immune cells induces metabolic changes to control 
microbial invasion. Glycolysis is needed for many functional 
tasks in activated macrophages, dendritic cells (DCs), and 
Th1 and Th17 lymphocytes, e.g., cytokine production and the 
development of innate immune memory. Consequently, accu-
mulation of lactate and extracellular acidification are prevalent 
in immune cells stimulated with pathogen-associated molecular 
patterns (PAMPs). In addition to the production by immune 
cells, lactate generated by neighbor client cells is a signal of tissue 
damage that impacts the macrophage response (1). Intracellular 
lactate stabilizes HIF1α protein (2, 3). An effect shared by other 
soluble factors found in tumoral and inflammatory milieus. For 
instance, succinate (4), pyruvate (2), adenosine (5), and hydro-
gen ions (6, 7). Extracellular lactate can activate the membrane 
receptor GPR81, which transduces extracellular signals through 
heterotrimeric G proteins in some cell types (8). A property 
shared by succinate, which enhances the function of some 
elements of the TLR family by engaging the G protein-coupled 
receptor GPR91 (9).
This plethora of metabolic changes entails the necessity 
of control mechanisms to avoid endoplasmic reticulum (ER) 
stress and cell death. Given that the unfolded protein response 
(UPR) is the main mechanism evolved to face this risk, it seems 
likely that elements of the UPR could support the metabolic and 
transcriptional rewiring elicited by the interaction of phagocytes 
with PAMPs. Among the components of the UPR, inositol-
requiring protein 1α (IRE1α) is critical to DCs activity since its 
endoribonuclease domain enables the activation of the X-box 
binding protein 1 (XBP1) transcription factor (10), which has 
been demonstrated to control DCs function under diverse physi-
ological and pathological conditions (11). XBP1 also sustains 
the production of TNFα and IL-6 in macrophages upon TLR-
driven activation (12). The clinical relevance of these findings 
is highlighted by the recent description of the role of XBP1 in 
the control of antitumor immunity and in the disruption of DCs 
homeostasis (13), as well as by sound hypotheses associating ER 
stress caused by HLA-B27 misfolding with IL-23 production in 
a rat model of spondyloarthritis (14) and the involvement of the 
IL-23/IL-17 axis in triggering tumor-elicited inflammation and 
tumor growth (15). These findings have encouraged the search 
of mechanisms associating the UPR with the transcriptional 
regulation of IL23A, the gene encoding the p19 chain of IL-23. 
One report described the involvement of C/EBP homologous 
protein (CHOP), a transcription factor activated in the UPR, 
when ER stress occurred in the presence of TLR agonists (16), 
and another report showed an increase of IL23A transcription 
upon inhibition of ataxia telangiectasia mutated kinase that 
correlated with an increase of the mRNA of spliced XBP1 (17). 
However, other studies have shown inhibition of the activating 
transcription factor 4 (ATF4)/CHOP branch of the UPR by TLR 
signaling (18, 19) and the actual involvement of ATF2 and NF-κB 
in the trans-activation of IL23A in the absence of a definite UPR 
activation (20, 21). Given the role of glycolysis during immune 
cell activation, 2-deoxy-d-glucose (2-DG) has been used as a 
surrogate of glucose deprivation in experimental studies. 2-DG 
is phosphorylated by hexokinase and this leads to the competitive 
inhibition of the enzyme (22). The use of 2-DG has disclosed 
the central function of glucose metabolism in bacterial and viral 
infection by showing in the latter model the lethality associated 
with 2-DG treatment by a mechanism involving type I IFN 
signaling and Ddit3/CHOP (23). However, 2-DG is not only a 
glucose mimetic, it is also the product resulting from the loss of 
the hydroxyl group attached at carbon-2 of mannose. Given that 
mannose is present in bodily fluids at much lower concentrations 
than glucose, 2-DG exerts a stronger competition for mannose 
metabolism than that exerted on glucose (24). This impinges on 
reactions using mannose as a substrate, including the formation 
of the dolichol-linked oligosaccharide Glc3-Man9-GlcNAc2 
involved in the initial steps of N-linked glycosylation. The 
functional relevance of this mechanism has been underscored 
in several models. For instance, 2-DG inhibits cell surface 
expression of NKG2D ligands (25), and reduces N-glycosylation 
and activity of COX-2 (26), a key enzyme for prostaglandin 
metabolism that contains four glycosylated asparagines, three of 
which are located in the active center and required for proper 
protein folding and catalysis (27). In this study, we analyzed the 
bioenergetic rewiring of human DCs stimulated with the fungal 
glucan zymosan and bacterial lipopolysaccharide (LPS) and 
investigated how the UPR modulates cytokine expression. Here, 
we show (i) a rapid enhancement of glycolysis and the mainte-
nance of oxidative phosphorylation in human DCs; (ii) robust 
activation of the IRE1α/XBP1 arm of the UPR by 2-DG in the 
presence of PAMPs, whereas the sole addition of 2-DG induced 
DDIT3/CHOP expression; and (iii) a robust enhancement of 
IL23A trans-activation by 2-DG associated with the induction of 
the UPR that shows some differences as to the arms triggered by 
the different PAMPs. An IRE1α/XBP1-dependent mechanism is 
involved in response to zymosan, whereas the response to LPS 
depends on IRE1α and PERK, as well as on the recruitment of 
CAAT/enhancer-binding protein β (C/EBPβ). Taken together, 
these findings demonstrate a strong influence of the UPR on the 
cytokine-signature elicited by stimulation of DCs.
MaTerials anD MeThODs
cells and reagents
Dendritic cells were obtained from human mononuclear cells 
collected from pooled buffy coats of healthy donors provided by 
Centro de Hemoterapia de Castilla y León. The differentiation 
of monocytes was carried out in the presence of GM-CSF and 
IL-4 for 5 days. Culture was carried out in RPMI 1640 medium 
containing 11.1 mM d-glucose, 4 mM L-glutamine, and 1 mM 
pyruvate. 10% FBS was maintained during the differentiation pro-
cess and reduced to 2% prior to the initiation of the experiments. 
Glucose starving experiments were carried out in BioWhittaker® 
RPMI 1640 medium, containing l-glutamine, without glucose. 
These conditions were used to replicate the experimental setting 
used in the Seahorse assays. For the characterization of the cell 
population as DCs, the expression of CD11c, CD40, and CD86 
was assayed. Briefly, cells were centrifuged for 5 min at 350g and 
resuspended in PBS. Ab was added at the concentration of 0.5 µg 
TaBle 1 | Primers for Q-PCR used in (A) human samples and (B) murine 
samples.
a. Primers for Q-Pcr used in human samples
IL1B FWD 5′-ATGATGGCTTATTACAGTGGCAA-3′
IL1B REV 5′-GTCGGAGATTCGTAGCTGGA-3′
IL10 FWD 5′-GAGAACAGCTGCACC CAC TT-3′
IL10 REV 5′-GGCCTTGCTCTTGTT TTCAC-3′
IL12A FWD 5′-GAGGCCTGTTTACCATTGGA-3′
IL12A REV 5′-TCAAGGGAGGATTTTTGTGG-3′
IL12B FWD 5′-CATGGGCCTTCATGCTATTT-3′
IL12B REV 5′-TTT GCATTG TCAGGTTTCCA-3′
IL23A FWD 5′-CATGGGCCTTCATGCTATTT-3′
IL23A REV 5′-TTT GCATTG TCAGGTTTCCA-3′ 
TNFA FWD 5′-GTTGTAGCAAACCCTCAAGC-3′
TNFA REV 5′-TTGAAGAGGACCTGGGAGTA-3′
DDIT3/CHOP FWD 5′-GCAGAGATGGCAGCTGAGTC-3′
DDIT3/CHOP AS 5′-AGCCAAGCCAGAGAAGCAGGGT-3′
PKM1 FWD 5′-GCATCATGCTGTCTGGAGAA-3′
PKM1 REV 5′-AACTATCAAAGCTGCTGCTA-3′
PKM2 FWD 5′-CTATCCTCTGGAGGCTGTGC-3′
PKM2 REV 5′-ACGATTATGGCCCCACTGCA-3′
XBP1 FWD 5′-TAAGACAGCGCTTGGGGATGGA-3′
XBP1 REV 5′-ATACCGCCAGAATCCATGGGGA-3′
GFPT1 FWD 5′-AATGCTGGTCCTGAGATTGG-3′
GFPT1 REV 5′-TTGATTTTCAGTGCCCCTTC-3′
GAPDH FWD 5′-GTCAGTGGTGGACCTGACCT-3′
GAPDH REV 5′-AGGGGAGATTCAGTGTGGTG-3′
B. Primers for Q-Pcr used in murine samples
sXbp1 FWD 5′-AAGAACACGCTTGGGAATGG-3′
sXbp1 REV 5′-CTGCACCTGCTGCGGAC-3′
Ddit3 FWD 5′-GTCCCTAGCTTGGCTGACAGA-3′
Ddit3 REV 5′-TGGAGAGCGAGGGCTTTG-3′
Il23a FWD 5′-AGGGAACAAGATGCTGGATT-3′
IL23aREV 5′-AGTAGATTCATATGTCCCGCT-3′
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for 5 × 105 cells and incubated for 45 min at 4°C. When the Ab 
was labeled with fluorochrome, cells were washed and fixed in 1% 
formaldehyde. In the case of non-labeled Ab, indirect immuno-
fluorescence was carried out using a labeled secondary Ab before 
washing and formaldehyde fixation steps. Isotype-matched 
irrelevant Ab was used as control. The analysis was performed in 
a Gallios Flow Cytometer. At least 10,000 cells were analyzed per 
sample. Kaluza software version 1.1 (Beckman Coulter) was used 
for quantitative data analysis. Ern1f/fVav1-Cre mice were obtained 
by Dr. Cubillos-Ruiz through a collaboration with Prof. Takao 
Iwawaki. Bone marrow from the femora and tibiae was used 
to obtain bone marrow-derived dendritic cells (BMDCs) from 
C57BL/6 [wild type (WT)], Ern1f/f, and Ern1f/fVav1-Cre mouse by 
incubation in media supplemented with 20 ng/mL recombinant 
murine GM-CSF. Cells were harvested at day 7 of differentiation 
and used directly for subsequent studies. The inhibitors of the 
ribonuclease activity of IRE1α, MK8866, and 4μ8C were a gift 
from Dr. John Patterson from MannKind Corporation, Valencia, 
CA, USA (28) and purchased to Tocris, respectively. The PERK 
inhibitors GSK2606414 and AMG PERK 44 (29, 30) were from 
Sellenckchem and Tocris, respectively. Tunicamycin was from 
Calbiochem. 2-DG, LPS, thapsigargin, and zymosan were 
from Sigma.
ethics statement
The study was approved by the Bioethical Committee of the 
Spanish Council of Research (CSIC) and the written informed 
consent of all healthy donors was obtained at Centro de 
Hemoterapia y Hemodonación de Castilla y León Biobank. The 
participants received written consent according to the regula-
tions of the Biobank and the researchers received the samples in 
an anonymous way. The process is documented by the Biobank 
authority according to the specific Spanish regulations. The 
animal experiments were carried out with permission of 
the local authority and conform to institutional standards. The 
ethics committee approved this procedure before starting the 
study.
Bioenergetic studies
Bioenergetic analyses of human DCs were carried out using the 
Seahorse Bioscience XF24 Extracellular Flux analyzer (Seahorse 
Bioscience). DCs were stimulated and either adhered immediately 
to polyornithine-coated Seahorse plates or after 4 h of incuba-
tion. To normalize the recording of data, results are referred to 
μg of protein. Extracellular acidification rate (ECAR) and oxygen 
consumption rate (OCR) were analyzed according to the XF Cell 
Mito Stress Test kit protocol in XF media (non-buffered RPMI 
medium 1640 containing 11.1 mM glucose, 4 mM l-glutamine, 
and 1  mM sodium pyruvate), under basal conditions, and in 
response to 1 µM oligomycin, 1.5 µM FCCP, and 100 nM rote-
none plus 1 µM antimycin A.
lactate assay
Lactate was assayed using a colorimetric test in cell supernatants 
centrifuged at 13,000g for 10 min to remove insoluble material 
and deproteinized by filtration with 3 kDa MWCO spin filters to 
remove lactate dehydrogenase. The soluble fraction was directly 
assayed using a Lactate Assay Kit II from Sigma.
XBP1 splicing assay
This was carried out by RT-PCRs with primers spanning the 
unspliced regions (Table  1). The PCR conditions were 5  min 
at 95°C (hot start), 45 cycles of denaturation at 95°C for 15  s, 
annealing at 60°C for 20 s and elongation at 72°C for 1 min. Final 
extension was carried out at 72°C for 5 min. Gel electrophoresis 
was carried out in 3% agarose and spliced XBP1 and unspliced 
XBP1 bands visualized by GelRed™ staining.
Pyruvate Kinase M (PKM) mrna 
expression
Pyruvate kinase M isoforms are generated by alternative splicing 
of mutually exclusive exons and differ in that PKM1 mRNA con-
tains exon 9 and lacks exon 10, whereas PKM2 mRNA includes 
exon 10 and lacks exon 9. RT-PCRs were carried out with primers 
designed in exon 8 and 11, to yield a 218 bp PKM1 mRNA and a 
183 bp PKM2 mRNA. This allows the quantitative assay of each 
isoform and the identification of the PCR amplicon by digestion 
with StuI, which recognizes an AGGCT sequence in exon 10 and 
yields a 149 and a 34 bp product in PKM2.
TaBle 2 | Primers used for ChIP.
IL12A Control FWD 5′-GCGAACATTTCGCTTTCATT-3′
IL12A Control REV 5′-ACTTTCCCGGGACTCTGGT-3′
IL23A X2-Box-C/EBP FWD 5′-CTCTAGCCACAGCAACCACA-3′
IL23A X2-Box-C/EBP REV 5′-GCCCGCCCTTTATACCAGCA-3′
IL23A X2-Box medial FWD 5′-CTTAGCTGTTTCACTCGATGTT-3′
IL23A X2-Box medial REV 5′-CAGGAGTTCTGGGTAGTCG-3′
IL23A X2-Box distal FWD 5′-TTCCATTGGTGTCCACCTTA-3′
IL23A X2-Box distal REV 5′-CTTTAGATTAAACATTTCCAGCA-3′
IL23A CHOP-C/EBP proximal FWD 5′-AGAACTCCTGGGCTTCCTAGCCAT-3′
IL23A CHOP-C/EBP proximal REV 5′-GGCCTCATTCTGACGTCATCCA-3′
IL23A CHOP-C/EBP FWD 5′-TAACGGTTTAGGCCCAGCTGAC-3′
IL23A CHOP-C/EBP distal REV 5′-TGTTGCGTGGCAGGAACTACA-3′
IL23A C/EBPβ FWD 5′-TTCCCAGTTCTCCAAGTTCC-3′
IL23A C/EBPβ REV 5′-TTGATTCCTACCTGATGCCC-3′
IL23A CRE FWD 5′-AGACCTCCATTCAGGACAAG-3′
IL23A CRE REV 5′-TCGAAGACGTCAGAATGAGG-3′
IL23A ATF2 FWD 5′-CATTGCAAACAGCTCACCAT-3′
IL23A ATF2 REV 5′-ATTTCCTCACTTCCTCCTGC-3′
GFPT1 × 2-Box FWD 5′-GAGTTTCTCCCTCCCTCTC-3′
GFPT1 × 2-Box REV 5′-GCTCCATTGAACCGCTCAC-3′
ChIP, chromatin immunoprecipitation.
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Western Blotting
Proteins were separated by electrophoresis in SDS/PAGE and 
transferred to nitrocellulose membranes. The membranes were 
used for the immunodetection of COX-2 (Santa Cruz sc-1745), 
CHOP (Santa Cruz sc-793), elongation initiation factor 2α (eIF2α, 
Cell Signaling #5324), P-Y705-STAT3 (Cell Signaling #9131), 
STAT3 (Cell Signaling #9132), PKM2 (Cell Signaling #3198S), 
IL-1β (Cell Signaling #12242), histone H3 (abcam ab1791), acetyl-
K9-histone H3 (Millipore #4-1003;), P-S10-histone H3 (Millipore 
#04-817), spliced XBP1 (sXBP1; BioLegend #619501), ATF6 
(abcam ab11909), HIF1α (Novus Biologicals NBP1-19779), and 
P-S52-eIF2α (Invitrogen #44-728G). For immunoblots directed 
to assay nuclear proteins, the nuclear extracts were obtained 
by using a nuclear extract kit (Active Motif). Anti-TATA-box-
binding protein (Diagenode TBPCSH-100) and anti-histone H3 
Ab were used for protein load control.
laser-scanning confocal Fluorescence 
Microscopy
Dendritic cells were seeded on poly-lysine-coated glass coverslips 
for 12 h and then stimulated with zymosan particles. Cells were 
fixed with 10% formaldehyde in PBS and stained with anti-HIF1α 
Ab or anti-PKM2 Ab and goat anti-rabbit IgG Ab labeled with 
Alexa-Fluor®480. The coverslips were observed by laser-scanning 
confocal fluorescence microscopy using a Leica TCS SP5 appa-
ratus equipped with a white-light laser and a Leica 63PL APO 
NA 1.40 oil immersion objective. Image analysis and subcellular 
colocalization fluorograms were generated and analyzed using 
the Leica confocal software package LAS AF Lite and Adobe 
Photoshop CS5.1 software.
real-time rT-Pcr
Total RNA was obtained by TRIzol/chloroform extraction and 
used for RT reactions. Cycling conditions were adapted to each 
set of primers. GAPDH was used as a housekeeping gene to 
assess the relative abundance of the different mRNA using the 
comparative cycle threshold method. The procedure was used to 
assay CHOP, IL10, IL23A, IL12A, IL12B, and IL1B mRNA. The 
sequences of the primers are shown in Table 1.
assay of arachidonate Metabolites by 
reversed Phase Ultraperformance liquid 
chromatography (UPlc) and electrospray 
ionization Quadrupole Time-of-Flight 
Mass spectrometry (Ms)
Lipids were extracted into ethanol from cell supernatants, eluted 
in methanol using Strata™ C-18E SPE cartridges (Phenomenex®), 
and evaporated to dryness under N2. The chromatographic sepa-
ration was conducted in an Acquity™ UPLC System equipped 
with an Acquity UPLC® BEH C18, 1.7 µm, 2.1 × 100 mm column 
(Waters). The chromatographic column was directly interfaced 
into the electrospray ionization source of a mass spectrometer 
(SYNAPT HDMS G2) from Waters. MS analysis was performed 
in negative ion mode using a MSE method that allows simultane-
ous detection of analytes through a low energy function (full 
scan) and a high energy function (collision energy) with ion 
partial fragmentation, as reported (31).
chromatin immunoprecipitation (chiP) 
assay
Chromatin immunoprecipitation assays were conducted with Ab 
against P-T71-ATF2 (Cell Signaling #9221), ATF4 (Santa Cruz 
sc-7583), C/EBPβ (Santa Cruz sc-150), and sXBP1 as previously 
reported (21). Briefly, cells were stimulated and then washed 
twice with PBS and fixed with 1% formaldehyde. Cross-linking 
was terminated by 0.125 M glycine. Crude nuclear extracts were 
collected by microcentrifugation and resuspended in a lysis 
buffer containing a high salt concentration. Chromatin sonica-
tion was carried out using a Bioruptor device from Diagenode. 
The chromatin solution was precleared by adding Protein A/G 
PLUS-Agarose for 30 min at 4°C under continuous rotation. After 
elimination of the beads, Ab was added for overnight incubation 
at 4°C, and then Protein A/G PLUS-Agarose was added and incu-
bated for an additional period of 2 h at 4°C. Beads were harvested 
by centrifugation at 4,000g and sequentially washed with lysis 
buffer high salt, wash buffer, and elution buffer. Cross-links were 
reversed by heating at 67°C in a water bath, and the DNA bound 
to the beads isolated by extraction with phenol/chloroform/isoa-
mylalcohol. Irrelevant Ab and sequences of the IL12A promoter 
were used as control of binding specificity. The sequences of the 
primers are shown in Table 2. Results are expressed as percentage 
of input.
statistical analysis
Data are represented as the mean ±  SEM and were analyzed 
with the Prism 4.0 statistical program (GraphPad Software). 
Comparison between experimental groups was carried out using 
the two-tailed Student’s t-test and ANOVA. Differences were 
considered significant for p < 0.05.
FigUre 1 | Effect of lipopolysaccharide (LPS) and zymosan on the 
bioenergetics of dendritic cells (DCs). (a) Recordings of the XF Mito Stress 
Test Kit protocol obtained in the presence of different concentrations of LPS. 
(a–c) DCs were stimulated for the times indicated in XF Seahorse assay 
medium in the presence of different concentrations of LPS and zymosan and 
then immediately adhered to poly-ornithine-coated plates for the assay of 
extracellular acidification rate (ECAR) and oxygen consumption rate (OCR). 
Results represent mean ± SEM of three independent experiments. *p < 0.05 
as compared to DCs maintained in the absence of stimuli.
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resUlTs
Metabolic Profile of Dcs
Stimulation of DCs with LPS produced a concentration-
dependent increase of the ECAR that could be detected imme-
diately after the addition of the stimuli in the XF Mito Stress 
Test (Figure 1A, right panel). Assessment of the OCR showed 
stable values in the case of LPS (Figure 1B) and a tendency to 
increase in the case of zymosan that did not reach statistical sig-
nificance (Figure 1C). The ECAR values were somewhat higher 
in response to zymosan than in the case of LPS and showed 
a more reproducible pattern of response (Figure  1C). These 
results are consistent with a fast and lasting increase of glycolysis 
upon a wide range of PAMPs concentrations, as judged from 
the net decrease of the OCR/ECAR ratio (Figures 1B,C, bottom 
panels).
Mechanisms Underlying Metabolic 
rewiring
One of the mechanisms promoting glycolysis in the presence of 
normoxia, usually termed Warburg effect or aerobic glycolysis, is 
the activation of HIF1 by the stabilization of its HIF1α subunit. 
This explains the induction of glycolytic enzyme expression, 
which in macrophages depends on the formation of a complex 
with pyruvate kinase M2 (PKM2) (32) that translocates to the 
nucleus and regulates the expression of proglycolytic enzymes 
(33). PKM2 may act as a protein kinase that phosphorylates 
STAT3 at Y705 (34) and histone H3 (35). This explains a posi-
tive feedback loop between HIF1 and STAT3 since Y705-STAT3 
activates HIF1α transcription (36, 37). In a previous study, we 
observed that both zymosan and LPS are robust activators of 
Y705-STAT3 phosphorylation through the induction of second-
ary mediators (38). In keeping with that report, the assay of 
P-Y705-STAT3 in nuclear extracts showed a time-course compat-
ible with its involvement in HIF1α expression (Figure 2A). As a 
correlate of enhanced transcriptional activity, zymosan induced 
global phosphorylation of S10-histone H3 and acetylation of 
K9-histone H3 (Figure 2B). The nuclear translocation of HIF1α 
was confirmed in immunofluorescence confocal microscopy 
studies (Figure  2C). The preferential expression of PKM2 
was confirmed by Western blot (Figure  2D) and by immuno-
fluorescence confocal microscopy, which showed the enzyme 
in the nuclei and in cytoplasm areas surrounding phagocytosed 
zymosan particles (Figure 2E), as well by analysis of its mRNA 
by RT-PCR. Assays with sets of primers that generate products 
distinguishable by the number of bp, showed a 149 and a 34 bp 
product in PKM2 upon treatment with StuI, whereas the PKM1 
amplicon was not digested (Figure 2F). Taken collectively, these 
data show the presence of P-Y705-STAT3 and HIF1α in the nuclei 
of zymosan- and LPS-stimulated DCs, as well as a high expres-
sion of PKM2 protein. However, the temporal pattern of HIF1α 
protein induction does not parallel the early changes of both 
OCR and ECAR, thus suggesting that other mechanisms may 
underlie the early rewiring of the bioenergetic profile of DCs, i.e., 
the association of hexokinase II with voltage-dependent anion 
channels in the outer mitochondrial membrane (39).
effect of glucose starvation and 2-Dg  
on cytokine expression
Given the increases of the ECAR induced by PAMPs, lactate 
levels were assayed. Lactate production was strongly blocked 
in glucose-starved cells and to a lesser extent in the presence 
FigUre 2 | Effect of dendritic cells (DCs) stimulation on Y705-STAT3 phosphorylation and HIF1α protein expression. (a,B) Nuclear fractions were used for the 
assay of STAT3 phosphorylation, HIF1α protein, and S10-phosphorylation and K9-acetylation of histone H3. (c) Nuclear translocation of HIF1α assayed by 
laser-scanning confocal immunofluorescence microscopy in resting and zymosan-treated DCs. (D) The expression of pyruvate kinase M2 (PKM2), pro-IL-1β, 
cyclooxygenase 2 (COX-2), and 5-lipoxygenase was immunodetected in DCs stimulated with zymosan and lipopolysaccharide (LPS) for different times in DCs 
preincubated for 1 h in the presence or absence of 10 mM 2-deoxy-d-glucose (2-DG) prior to the addition of the pathogen-associated molecular patterns (PAMPs). 
(e) Location of PKM2 to cytoplasm and nucleus assayed by laser-scanning confocal immunofluorescence microscopy in DCs stimulated with zymosan.  
(F) Confirmation by RT-PCRs and selective digestion by StuI of the PKM2 amplicon of the predominant expression of PKM2. TBP indicates TATA-box-binding 
protein. Gly indicates glycosylated and unGly, unglycosylated.
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of 10  mM 2-DG (Figure  3A). Consistent with seminal studies 
on non-opsonic phagocytosis, in which 2-DG did not reduce 
zymosan uptake even when ATP production was blocked 
(40, 41), DCs showed robust phagocytosis in the presence of 
2-DG and also exhibited a robust ability to release arachidonic 
acid (Figure 4), thus suggesting that the effect of 2-DG cannot 
be explained by an effect on the earliest steps of DCs activation. 
Unexpectedly, the mRNA levels of various cytokines showed 
notable differences under glucose-limiting conditions and in the 
presence of 2-DG. The most striking effect was observed on the 
induction of IL23A, which increased ~ 20-fold 24 h after stimula-
tion (Figure 3B). The assay of IL-23 protein showed a net increase 
in the case of LPS, but not in the case of zymosan (Figure 3C). 
A likely explanation is that the high production of IL-23 protein 
induced by zymosan under these conditions could not increase 
because, unlike LPS, zymosan triggers low transcription of the 
gene encoding the p40 chain (IL12B), which is a limiting step for 
the production of this heterodimeric cytokine. The assay of other 
cytokines showed prominent changes in response to LPS, includ-
ing an increase of IL12A mRNA and a reduction of IL10 and 
IL1B mRNA. The expression of pro-IL-1β was also blunted in the 
presence of 2-DG (Figure 2D). Given that these findings could 
not be explained by a simple blockade of glucose metabolism, 
alternative mechanisms were postulated, focusing on the effect 
of 2-DG on mannose metabolism, N-glycosylation reactions, 
and the possible activation of the UPR as a result of potential 
protein misfolding. Consistent with this hypothesis, stimulation 
of DCs with zymosan and LPS in the presence of 2-DG induced 
robust splicing of the XBP1 mRNA (Figure  3D), whereas the 
sole addition of 2-DG or PAMP did not. In sharp contrast, XBP1 
splicing was not observed in DCs starved of glucose for up to 18 h 
and stimulated with PAMPs (not shown). Given the prominent 
enhancement of aerobic glycolysis induced by PAMPs and a 
recent report underscoring that this process reduces the supply 
of fructose-6-phosphate to glutamine-fructose-6-phosphate 
transaminase 1 (GFPT1), the enzyme that transfers the amino 
group of l-glutamine to yield glucosamine-6-phosphate for 
N-glycan biosynthesis (42), our data point out that the coinci-
dental inhibition of mannose metabolism by 2-DG and of the 
hexosamine biosynthetic pathway by aerobic glycolysis show 
optimal conditions for N-glycosylation blockade. XBP1 splicing 
was observed after 2 h of incubation (Figure 3E) and was blunted 
by 1 mM mannose and the inhibitor of the endonuclease activity 
of IRE1α MKC8866 (Figure 3F). Notably, these treatments also 
inhibited the effect of 2-DG on the induction of IL23A elicited 
by zymosan (Figure 3G), whereas this effect was less definite in 
FigUre 3 | Effect of 2-deoxy-d-glucose (2-DG) on lactate production, cytokine expression, and XBP1 splicing. (a) Production of lactate by dendritic cells (DCs) in 
the presence and absence of 11.1 mM glucose and in the presence of 10 mM 2-DG. (B) Effect of 2-DG or glucose starvation on the expression of the mRNA of 
different cytokines in DCs stimulated with 1 mg/mL zymosan and 10 µg/mL lipopolysaccharide (LPS) for the times indicated. (c) Effect of 2-DG on the production of 
IL-23 protein and on (D) XBP1 mRNA splicing. (e) Time course of XBP1 mRNA splicing and (F) effect of 1 mM mannose and 10 µM MKC8866 on the splicing of 
XBP1 mRNA elicited by 2-DG. (g) Effect of mannose and inositol-requiring protein 1α (IRE1α) endonuclease inhibitors on the mRNA expression of IL23A and IL10. 
Results show mean ± SEM of 5 to 10 experiments in the mRNA assays. XBP1 mRNA splicing assays have been carried out at least twice. sXBP1 stands for  
spliced X-box binding protein 1, uXBP1 stands for unspliced XBP1 (*p < 0.05, **p < 0.01).
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the case of LPS. The effect of 2-DG on IL10 mRNA induction 
was less sensitive to mannose and IRE1α inhibitors (Figure 3G, 
right panel). These data suggest that the effect of 2-DG on IL23A 
expression can be explained by interference with mannose 
metabolism and associated with the activation of the UPR, 
whereas the effect on IL10 mRNA expression seems dependent 
on other mechanisms.
effect of lactate
Since the distinct effects observed on IL23A and IL10 mRNA 
expression elicited by 2-DG could not be explained by a sole 
mechanism and given that 2-DG reduced lactate production 
(Figure  3A) and blocked pro-IL-1β expression (Figure  2D), 
the effect of 2-DG on the lactate/HIF1 route was addressed. 
2-DG inhibited the expression of HIF1α induced by zymosan 
FigUre 4 |  Characterization of the dendritic cell (DCs) population and effect of 2-deoxy-d-glucose (2-DG) on zymosan phagocytosis and arachidonate release. (a) 
Expression of CD11c, CD40, and CD86 in monocyte-derived DCs. (B) Effect of 2-DG on the phagocytosis of Alexa Fluor® 488 dye-conjugated zymosan particles. 
DCs were incubated in the presence and absence of 10 mM 2-DG for 1 h. At the end of this period, Alexa Fluor® 488-conjugated zymosan particles were added at 
a concentration of three particles per DC, and then the uptake of zymosan particles was assayed by flow cytometry. The dot plots represent side scatter (SS) versus 
forward scatter (FS) intensities in the left panels, and SS intensity versus Alexa Fluor® 488 green fluorescence in the middle and right panels. (c) DCs were 
stimulated with 1 mg/mL zymosan particles for 1 h in the presence and absence of 2-DG and the supernatants collected for the assay of the most abundant 
eicosanoids. PGE2 was not detected under these conditions. LTB4 indicates leukotriene B4.
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FigUre 5 | Effect of lactate and 2-deoxy-d-glucose (2-DG) on the expression of HIF1α protein and cytokines. (a) Effect of 2-DG on HIF1α protein expression over 
different times of stimulation. (B) Dendritic cells (DCs) were stimulated for 4 h with 1 mg/mL zymosan in the presence and absence of 2-DG and 15 mM lactate and 
the expression of HIF1α protein assayed. (c) Expression of the mRNA of several cytokines in the presence and absence of 15 mM sodium lactate. (D) Absence of 
X-box binding protein 1 (XBP1) splicing upon lactate and lactic acid treatment. Results show mean ± SEM of three experiments in (c) and two assays of XBP1 
mRNA splicing (*p < 0.05).
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(Figure  5A). An effect countered by lactate (Figure  5B). 
Stimulation of DCs in the presence of sodium lactate did not 
influence the expression of IL1B mRNA. In contrast, IL10 and 
IL23A mRNA expression showed a trend to increase (Figure 5C). 
Treatment with LPS and zymosan in the presence of either sodium 
lactate or lactic acid did not induce XBP1 splicing (Figure 5D). 
These results confirm the involvement of the lactate/HIF1 system 
in pro-IL-1β expression and show that the effect of lactate on the 
mRNA expression of IL10 and IL23A is independent of XBP1 
splicing.
effect of l-glutamine
The effect of l-glutamine starvation was addressed given its 
involvement in both the hexosamine biosynthesis pathway 
and the tricarboxylic acid cycle. In addition, glutaminolysis 
contributes to restore metabolic homeostasis by enhancing the 
XBP1- and α-ketoglutarate-dependent expression of GFPT1 (43). 
l-Glutamine removal induced a significant increase of lactate 
production in resting DCs after 24 h of incubation. In contrast, 
lactate levels were not significantly affected in the absence of 
l-glutamine after stimulation with zymosan, oligomycin or LPS 
FigUre 6 | Effect of l-glutamine starvation on cytokine production. (a–c) Dendritic cells (DCs) were maintained for the times indicated in the presence and absence 
of 4 mM l-glutamine. At the end of these periods, the supernatant was collected for the assay of lactate (a) and the RNA extracted for the assay  
of the expression of cytokines (B) and X-box binding protein 1 (XBP1) splicing (c). Results show mean ± SEM of three experiments (*p < 0.05).
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(Figure 6A). IL10 mRNA expression showed a trend to reduc-
tion in the absence of l-glutamine that reached statistical differ-
ence at 24 h (Figure 6B). Stimulation of DCs in the absence of 
l-glutamine did not induce XBP1 splicing, although the effect 
of 2-DG was somewhat more prominent in the absence of 
l-glutamine (Figure 6C).
The UPr regulates IL23A trans-activation
Given the association of XBP1 splicing with the enhanced expres-
sion of IL23A mRNA, our experiments then focused on whether 
the UPR induced by other mechanisms showed similar results 
and the possible involvement of the PERK/eIF2α/ATF4/CHOP 
branch of the UPR. P-S52-eIF2α was detected to a low extent 
in resting DCs and did not increase upon 2-DG treatment and 
PAMPs stimulation (Figure 7A), in agreement with a recent report 
showing that LPS did not affect eIF2α phosphorylation (44). The 
mRNA expression of DDIT3/CHOP was enhanced by 2-DG and 
blunted by mannose in the presence of PAMPs (Figure 7B), thus 
suggesting that mannose may counter some of the mechanisms 
triggered by the stimuli by acting as a substrate for the formation 
of dolichol-linked oligosaccharide. Tunicamycin and thapsigar-
gin induced similar effects to those elicited by 2-DG on IL23A 
and IL10 mRNA expression (Figure 7C) as well as on XBP1 splic-
ing (Figure 7D). Consistent with the inhibitory activity of 2-DG 
on COX-2 N-glycosylation (Figure 2D), tunicamycin, a robust 
inhibitor of this posttranslational modification, caused the same 
effect. In contrast, thapsigargin, which elicits the UPR via SERCA 
inhibition and does not interfere with N-glycosylation reactions, 
failed to do so (Figure  7E). These data indicate that ER stress 
responses, rather than N-glycosylation inhibition alone, under-
pin the cytokine signature induced by ER stressors. In keeping 
with previous results (21), the expression of CHOP protein was 
detectable in the nuclear fractions of resting DCs and showed a 
net trend to decrease after stimulation by zymosan (Figure 7F). 
FigUre 7 | Continued
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A recent report has disclosed that PERK inhibition decreases 
UPR-dependent inflammation via attenuation of eIF2α phos-
phorylation and reduction of the transcription of inflammatory 
genes as a result of translational repression (45). Consistent with 
this mechanism, PERK inhibition with GSK2606414 reduced the 
induction of DDIT3 and IL23A mRNA elicited by LPS in the pres-
ence of 2-DG. A similar result was obtained with the pyrazole-
based PERK inhibitor AMG PERK 44, which has been found 
recently to lack the RIPK1-inhibitory effect recently disclosed for 
GSK2606414 (30). The effect of both compounds was less evident 
in zymosan-treated DCs and suggests a stimulus-dependent 
recruitment of the different arms of the UPR (Figure  7G). 
Consistent with the selectivity of GSK2006414 on the PERK 
route, XBP1 splicing was not inhibited (Figure 7H). Stimulation 
with zymosan induced ATF6 cleavage to an extent higher than 
that produced by the sole addition of 2-DG, as well as a noticeable 
change in the mobility of full-length ATF6, most likely due to 
the underglycosylation of the protein before cleavage by site-1 
proteases (46). Combination of zymosan with 2-DG did not 
enhance ATF6 cleavage and the effect of LPS was similar to the 
one elicited by the sole addition of 2-DG (Figure 7I).
Given that the trans-activation of IL23A induced by zymosan 
depends on at least NF-κB proteins and ATF2 (21), the interaction 
of P-T71-ATF2 with the IL23A promoter was assayed. The binding 
was partially inhibited in the presence of 2-DG, thus suggesting 
that other transcription factors might be engaged under these 
conditions (Figure 8A). The involvement of sXBP1 was then con-
sidered the leading hypothesis because of (i) the robust splicing 
FigUre 7 | Unfolded protein response (UPR) and cytokine expression. (a) Time course of elongation initiation factor 2α (eIF2α) phosphorylation in dendritic cells 
(DCs) incubated with 2-deoxy-d-glucose (2-DG) and effect of zymosan and lipopolysaccharide (LPS) after preincubation with 2-DG for 1 h and stimulation for 4 h. 
(B,c) DCs were stimulated with LPS or zymosan for 4 h in the presence of different additions and the mRNA of DDIT3/C/EBP homologous protein (CHOP), IL23A, 
and IL10 assayed. (D) Splicing of X-box binding protein 1 (XBP1) and unglycosylation of cyclooxygenase 2 (COX-2) (e) after 4 h of stimulation in the presence of the 
indicated additions. (F) Expression of CHOP protein in the nuclear extracts of DCs stimulated in the presence and absence of 2-DG. (g) Effect of 1 µM 
GSK2606414 and 10 µM AMG PERK 44 on IL23A and DDIT3/CHOP mRNA expression. The drugs were added 30 min prior to preincubation with 2-DG and the 
mRNA extracted after 4 h of incubation in the presence of the stimuli. (h) Lack of effect of GSK2606414 on XBP1 splicing. (i) Effect of 2-DG on ATF6 cleavage in 
DCs maintained for 1 h in the presence or absence of 2-DG and then stimulated for 1 h with zymosan or LPS. Experiments were carried out at least in duplicate 
(*p < 0.05; **p < 0.01).
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of XBP1 and the effect of IRE1α endonuclease inhibitors; (ii) the 
presence of three X-boxes in the IL23A promoter identified using 
the TRANSFAC database (21); and (iii) the role of XBP1 in the 
regulation of diverse targets exhibiting a wide array of sequence 
motifs (12, 47). sXBP1 protein was detected in the nuclear extract 
of DCs, but its expression did not show significant changes upon 
various treatments nor in the presence of MKC8866 (Figure 8B). 
2-DG increased the binding of sXBP1 to the three X-boxes in the 
IL23A promoter (Figure 8C), which suggests the involvement of 
this transcription factor in the enhancement of IL23A expression 
and that in addition to the expression of the protein, either post-
translational modifications (48, 49) or formation of an enhanceo-
some with other factors may be necessary for full development of 
transcriptional activity (50). Since sXBP1 also plays a central role 
in the control of the hexosamine biosynthetic pathway by regulat-
ing the expression of GFPT1 (51), the expression of this enzyme 
and the binding of sXBP1 to an X-box placed 147 bp upstream 
of the transcription initiation nucleotide were addressed. Resting 
DCs showed a high expression of GFPT1 mRNA, which was 
significantly enhanced when DCs were stimulated with either 
zymosan or LPS in the presence of 2-DG (Figure 8E). Notably, 
binding of sXBP1 to the X-box of GFPT1 showed a parallel 
enhancement under these conditions (Figure 8F). These results 
confirm the presence of detectable amounts of sXBP1 protein 
in resting DCs in the absence of definite XBP1 mRNA splicing 
and suggest that in addition to the expression of protein, post-
translational modifications or interaction with other factors may 
be necessary for its transcriptional activity.
FigUre 8 | Transcription factors involved in IL23A and glutamine-fructose-6-phosphate transaminase 1 (GFPT1) mRNA expression. (a) Effect of 2-deoxy-d-glucose 
(2-DG) on the binding of P-T71-ATF2 to the ATF2 consensus binding sequence in the IL23A promoter. (B) Expression of spliced X-box binding protein 1 (sXBP1) 
protein in nuclear fractions of dendritic cells (DCs) stimulated with zymosan and lipopolysaccharide (LPS) in the presence and absence of 2-DG and MKC8866.  
(c) Effect of 2-DG on the binding of sXBP1 to the X-boxes of the IL23A promoter after 1 h of stimulation with zymosan and LPS. (D) Binding of CAAT/enhancer-
binding protein β (C/EBPβ) to C/EBP sites in the IL23A promoter. (e) Effect of 2-DG on the mRNA expression of GFPT1 mRNA in DCs stimulated for 4 h with 
zymosan and LPS. (F) Binding of sXBP1 to the X-box of the GFPT1 promoter 1 h after addition of the stimuli. Results show mean ± SEM of three to five 
experiments (*p < 0.05).
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2-Dg enhances c/eBPβ Binding activity
IL23A trans-activation by LPS has been associated with a set 
of factors including NF-κB, cAMP response element-binding 
protein (CREB), and C/EBPβ. Consistent with this notion 
and the finding that inhibition of the IRE1α and PERK routes 
showed stimulus-dependent effects, the binding of C/EBPβ 
to three sites in the IL23A promoter, two of which are close 
to two X-boxes and to a κB-site (21), was addressed. Unlike 
zymosan, 2-DG increased robustly the binding of C/EBPβ to 
the three sites (Figure 8D), thus suggesting the association of 
this factor with the enhancing effect of 2-DG on the expression 
of IL23A induced by LPS.
effect of the Deletion of Ern1 on Il23a 
expression
Since the biochemical and pharmacological experiments sug-
gested that the effect of the UPR on IL23A expression could be 
explained by a stimulus-dependent recruitment of the IRE1α 
and the PERK routes, experiments were carried out in mice with 
hematopoietic system-specific deletion of Ern1, i.e., the gene 
FigUre 9 | Effect of Ern1 deletion on Il23a mRNA expression. (a) The efficiency of gene deletion in Ern1f/fVav1-Cre was assayed by real-time RT-PCR of spliced 
X-box binding protein 1 (sXBP1) and compared with the results in Ern1f/f mice. (B) Induction of Ddit3/Chop mRNA and (c) expression of Il23a mRNA. (D) C57BL/6 
mice were used to address the effect of protein kinase R-like endoplasmic reticulum kinase (PERK) inhibition on Il23a mRNA expression. 1 µM GSK2606414 was 
added 30 min prior to the incubation with 2-deoxy-d-glucose (2-DG). The conditions of the experiments in bone marrow-derived dendritic cells (BMDCs) were  
similar to those used for dendritic cells (DCs). Results show mean ± SEM (*p < 0.05).
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encoding Ire1α (Ern1f/fVav1-Cre mice). As shown in Figure 9A, 
the sole addition of 2-DG induced Xbp1 splicing in BMDCs 
from Ern1f/f mice, which is a salient difference as compared to 
human DCs, in which both 2-DG and PAMPs are required for 
XBP1 splicing. Ern1f/fVav1-Cre mice did not show Xbp1 splicing, 
whereas Ddit3 mRNA expression was not significantly affected 
(Figure 9B). Notably, a substantial reduction in Il23a expression 
was observed in the Ern1f/fVav1-Cre mice upon treatment with 
both LPS and zymosan in the presence of 2-DG, as compared 
to the Ern1f/f mice (Figure  9C). Consistent with the results 
observed in DCs, pharmacological blockade of the PERK route 
with GSK2606414 inhibited Il23a mRNA expression in WT 
mice stimulated with LPS (Figure 9D). These results suggest the 
involvement of the Ire1α route in response to both zymosan and 
LPS and of the PERK route in the case of LPS.
DiscUssiOn
This study shows an increase of the extent of glycolysis along 
a wide array of concentrations of PAMPs and a rather stable 
tendency of the OCR in human DCs. The expression of HIF1α 
protein shows a robust increase after ~4  h, which lags behind 
the glycolytic changes and suggests its involvement in the main-
tenance of the metabolic rewiring. These results are consistent 
with the occurrence of an early translocation of hexokinase II 
to the outer mitochondrial membrane, where it takes advantage 
of a privileged access to mitochondrial ATP. Given the central 
role of hexokinase and the widespread use of its inhibitor 2-DG, 
we addressed the effect of glucose starvation and 2-DG on 
cytokine expression. Whereas glucose starvation reduced the 
production of lactate after DCs stimulation to levels similar to 
those observed in resting DCs, 2-DG produced a less intense 
reduction. Unexpectedly, the expression of some cytokines 
showed marked differences, being the effect on IL23A mRNA 
most outstanding and seemingly dependent on the IRE1α/XBP1 
arm of the UPR. The different effect of 2-DG on the induction 
of IL10 in response to zymosan and LPS agrees with the distinct 
trans-activating mechanisms elicited by these stimuli (38). At first 
glance, the effect of 2-DG could be associated with the reduction 
of lactate production, in keeping with the well-known function 
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of lactate as a promoter of the differentiation of macrophages into 
the type M2 (3), and the observation that exogenous lactate at 
concentrations higher than those detected in the extracellular 
medium increased IL10 mRNA. However, a correlation of lactate 
production with IL10 mRNA expression could not be established 
since glucose deprivation was more efficient than 2-DG to reduce 
lactate production, while it did not affect IL10 mRNA expression. 
Although an unambiguous explanation of these findings cannot 
be given, an effect of lactate via GPR81 is plausible, since we have 
observed Ca2+ transients by perfusing DCs with 15 mM lactate 
(data not shown). In addition, high concentrations of lactate 
have been found to induce GPR81-independent inhibition of 
pro-inflammatory responses and LPS-induced glycolysis in bone 
marrow macrophages (52). A different effect of glucose depriva-
tion and 2-DG on cytokine production had been reported in 
human CD4 and CD8 T cells, although no mechanistic explana-
tion was provided (53). A recent study has underscored the role of 
l-glutamine in the hexosamine biosynthesis pathway by enhanc-
ing the sXBP1- and α-ketoglutarate-dependent expression of 
GFPT1 via mTORC2 activation, in an attempt to restore metabolic 
homeostasis. However, this was only observed after very long 
starvation or when both l-glutamine and glucose were exhausted 
(43). Since the immune response entails the coordination of gene 
expression and protein output to avoid the risk of building-up 
unfolded proteins, and 2-DG has been associated with the induc-
tion of the UPR via competition with N-glycosylation reactions 
(24), the involvement of the transcription factors involved in the 
UPR was taken into account. The role of CHOP was proposed in 
a study carried out using a combination of LPS and tunicamycin 
(16), and the involvement of sXBP1 was suggested by showing 
that inhibition of ataxia telangiectasia mutated kinase by μM 
concentrations of the compound KU55933 increased the abun-
dance of sXBP1 mRNA and IL23A transcription (17). However, 
the experimental setting of those studies did not fit well with 
the actual occurrence of UPR and current views stand out the 
cooperation of NF-κB proteins with ATF2, CREB, and C/EBPβ 
as the central mechanism involved in IL23A trans-activation by 
PAMPs (20, 21, 50, 54).
The induction of the UPR by 2-DG and tunicamycin has 
mechanistic commonalities since both drugs impinge on protein 
glycosylation. However, thapsigargin, which acts via SERCA 
inhibition, showed similar effects. These results indicate that 
the UPR rather than inhibition of N-glycosylation on its one is 
involved in IL23A trans-activation. Experiments supported the 
activation of XBP1 by combination of 2-DG and PAMPs and its 
involvement in the regulation of IL23A in the zymosan system. 
As to the PERK/eIF2α/ATF4/CHOP route, the data indicate a 
role of PERK in the LPS model, in agreement with the known link 
between translational repression and transcription of inflamma-
tory genes (45). eIF2α phosphorylation has been associated with 
the enhancement of NF-κB activity via decreased levels of IκBα 
protein, given the short life of this protein (55). A PERK/JAK1/
STAT3 route has been reported as a novel mechanism that contrib-
utes to ER stress-induced inflammation. Detection of ER stress by 
the ER-lumenal sensor domain dimerizes PERK and brings the 
interacting JAKs into proximity to allow trans-autophosphoryl-
ation, phosphorylation of the cytoplasmic domain of PERK at 
Y585 and Y619 with the ensuing activation of its kinase activity, 
and S52-eIF2α and Y705-STAT3 phosphorylation (56). Notably, 
P-Y705-STAT3 can be detected in the DCs system at early times 
as a result of the residual effect of the cytokines GM-CSF and 
IL-4 used to induce DCs differentiation (57), and later on as a 
result of the TRIF/TRAM branch of the LPS/TLR4 system or 
through the induction of secondary mediators (38). The interplay 
between the PERK and IRE1α routes through STAT3 (Figure 10) 
is supported by recent data showing that STAT3 plays a critical 
role in the activation of a non-canonical UPR cascade involving 
Ire1α and Xbp1 under combined cytokine stimulation (58). Our 
finding of a stable phosphorylation of eIF2α (Figure 7A) agrees 
with a recent report showing similar results in M2-polarized 
macrophages stimulated with LPS, thus suggesting that some 
stimuli activate the UPR in the absence of a stimulatory effect on 
eIF2α phosphorylation (44).
Further mechanistic insight was provided by experiments in 
the Ire1α-deficient mice, by showing that a significant part of the 
effect could be associated unambiguously with the IRE1α route. 
In the case of zymosan it also involved sXBP1, although other 
mechanisms cannot be ruled out, e.g., the formation of a complex 
of IκB kinase (IKK) with IRE1α through the adaptor protein 
TRAF2, given that NF-κB activation is impaired under ER stress 
conditions in IRE1α knockdown cells and Ern1−/− mouse embry-
onic fibroblasts (59). A recent study has enlarged the reciprocity 
of connections between IKK and the IRE1α route by showing that 
IKKβ directly phosphorylates sXBP1 at T48 and S148 residues 
(49). Surprisingly, another study has unveiled a role of XBP1 as a 
moonlighting protein, since its antilipogenic activity is mediated 
through a protein-protein interaction that ultimately reduces 
cytoplasm-to-membrane translocation of PKCε (60).
Our suggestion that the PERK branch is involved in response 
to LPS mainly stems on pharmacological studies. Given that 
GSK2606414 has been recently reported to be an active inhibitor 
of RIPK1 in TNFα-RIPK1 kinase-dependent models, we extended 
the experiments using AMP PERK 44 (30), which does not exhibit 
that effect. Results are consistent with PERK activity inhibition 
and do not suggest RIPK1 involvement in IL23A induction. An 
open question is the association of C/EBPβ with the UPR. C/EBPβ 
has been found to induce the transcriptional activation of XBP1  
(61, 62) and, conversely, C/EBPβ is induced by XBP1 via an X-box 
present in human cells that is absent in rats and mice (63), as 
well as through the PERK route (64). In addition, C/EBPβ is fully 
active in unstimulated macrophages and poised to be recruited 
into enhanceosomes to team up with other factors to stimulate 
transcription, given its well-known function as a pioneer factor 
that promotes the opening of silent chromatin (49, 65, 66). The 
present results are of clinical relevance because DCs in tumor 
milieus show an activation of XBP1 that blunts the immune 
response and favors tumor cell progression (13). This agrees with 
a previous report where the poor prognosis of triple-negative 
breast cancers correlated with the assembly of a transcriptional 
complex of XBP1 and HIF1α (67). The present study extends the 
clinical relevance of those reports by showing that the stimulation 
by PAMPs under conditions of ER stress imprints the cytokine 
response into a pattern favorable to tumor progression. In fact, the 
production of IL-23 by tumor-associated myeloid cells in tissues 
FigUre 10 | Explanatory diagram of the routes involved in the transcriptional regulation of the p19 chain of IL-23 during the unfolded protein response (UPR). The 
structure of the IL23A proximal promoter is shown on top of the diagrams underscoring the regulatory elements where activating transcription factor 2 (ATF2), X-box 
binding protein 1 (XBP1), NF-κB, and CAAT/enhancer-binding protein β (C/EBPβ) bind. The formation of enhanceosomes involving NF-κB, XBP1, and C/EBPβ 
seems most likely and the combinatory usage of elements may depend on the nature of the stimulus. The inositol-requiring protein 1α (IRE1α) route is involved in all 
cases and impinges at least on NF-κB activation and on XBP1 activity in the case of zymosan. STAT3 is activated by fungal patterns via secondary mediators not 
yet identified, whereas in the case of lipopolysaccharide (LPS) the activation depends on IFNβ and IRF3 downstream of the TRIF/TRAM adaptors of the LPS/TLR4 
system. C/EBPβ and the PERK route seem more relevant in the case of LPS. Discontinuous lines indicate routes non-addressed in the current experiments but 
which are supported on other studies (38, 49, 59–64).
16
Márquez et al. The UPR Controls IL-23 in DCs
Frontiers in Immunology | www.frontiersin.org June 2017 | Volume 8 | Article 639
accessible to microbial products is a major driver of tumor growth, 
for instance in colon cancer (15). Noteworthy, GM-CSF exerts a 
robust effect on atherogenesis via the production of IL-23 (68) 
and a recent report has shown that inhibition of the ribonuclease 
activity of Ire1α by 4μ8C counteracts atherosclerosis progression 
(69). Therefore, a major contribution of Ire1α to atherogenesis 
may rely on its ability to enhance IL-23 production. Most recent 
reports have confirmed in clinical studies the beneficial effect of 
blocking IL-23 activity in psoriasis (70) and Crohn’s disease (71). 
Most remarkable, increasing target selectivity with risankizumab, 
an antibody reactive to the p19 chain, induced clinical responses 
superior to those associated with ustekinumab, an antibody reac-
tive to the p40 chain, which is shared by both IL-12 p70 and IL-23 
(70). In summary, these data show a net enhancement of glyco-
lysis in DCs stimulated with PAMPs. The use of the hexokinase 
inhibitor 2-DG disclosed robust changes of IL23A transcription 
that were not reproduced by glucose starvation and pointed to the 
activation of the UPR via interference with mannose metabolism 
and N-glycosylation reactions. These data indicate that the cur-
rent mechanism of transcriptional regulation of IL23A induced 
by PAMPs via the recruitment of NF-κB, ATF2, and C/EBPβ can 
be reinforced by the recruitment of the IRE1α and PERK arms of 
the UPR. An explanatory diagram of the routes involved is shown 
in Figure 10.
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